Search

Author/Creator Chen, Thomas C.

1. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Issue 2 (28th February 2016)

Authors:
Jhaveri, Niyati; Agasse, Fabienne; Armstrong, Don; Peng, Lilei; Commins, Deborah; Wang, Weijun; Rosenstein-Sisson, Rachel; Vaikari, Vijaya Pooja; Santiago, Shayane V.; Santos, Tiago; Chen, Ligang; Schönthal, Axel H.; Chen, Thomas C.; Hofman, Florence M.
Journal:
Cancer letters
Issue:
Volume 371:Issue 2(2016)
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells. (1st August 2017)

Authors:
Chen, Thomas C.; Yu, Jiali; Nouri Nigjeh, Eslam; Wang, Weijun; Myint, Phyo Thazin; Zandi, Ebrahim; Hofman, Florence M.; Schönthal, Axel H.
Journal:
Cancer letters
Issue:
Volume 400(2017)
Page Start:
161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity. Issue 23 (28th May 2015)

Authors:
Schijns, Virgil E.J.C.; Pretto, Chrystel; Devillers, Laurent; Pierre, Denis; Hofman, Florence M.; Chen, Thomas C.; Mespouille, Pascal; Hantos, Peter; Glorieux, Philippe; Bota, Daniela A.; Stathopoulos, Apostolos
Journal:
Vaccine
Issue:
Volume 33:Issue 23(2015)
Page Start:
2690
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗